These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2788775)

  • 1. The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma proteins.
    Ayub M; Levell MJ
    J Steroid Biochem; 1989 Aug; 33(2):251-5. PubMed ID: 2788775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens.
    Brown TR; Rothwell SW; Sultan C; Migeon CJ
    Steroids; 1981 Jun; 37(6):635-48. PubMed ID: 6457421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of testicular 17 alpha-hydroxylase and 17,20-lyase but not 3 beta-hydroxysteroid dehydrogenase-isomerase or 17 beta-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs.
    Ayub M; Levell MJ
    J Steroid Biochem; 1987 Nov; 28(5):521-31. PubMed ID: 2824931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
    Steinsapir J; Mora G; Muldoon TG
    Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione.
    Ayub M; Levell MJ
    Biochem Pharmacol; 1990 Oct; 40(7):1569-75. PubMed ID: 2222512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.
    Brinkmann AO; Lindh LM; Breedveld DI; Mulder E; Van Der Molen HJ
    Mol Cell Endocrinol; 1983 Oct; 32(2-3):117-29. PubMed ID: 6227511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor binding characteristics in the cytosol of the rat dorsolateral prostate gland and the Dunning R-3327 prostatic adenocarcinoma.
    Rowley DR; Thompson SA; Lubaroff DM; Heidger PM
    Prostate; 1984; 5(1):101-11. PubMed ID: 6607463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
    Huang JK; Bartsch W; Voigt KD
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):569-76. PubMed ID: 2930988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiandrogens on the binding of androgen to cytosol and nuclei of hamster sebaceous glands.
    Takayasu S
    Arch Dermatol Res; 1979 Feb; 264(1):49-54. PubMed ID: 443861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells.
    Hackenberg R; Hofmann J; Hölzel F; Schulz KD
    J Cancer Res Clin Oncol; 1988; 114(6):593-601. PubMed ID: 2974456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
    Berrevoets CA; Veldscholte J; Mulder E
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative assay for the cytoplasmic androgen receptor using [3H]dihydrotestosterone in the presence of NAD+-nucleosidase.
    Moeller H; Oettling G; Fiederer B; Brügmann G
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):153-60. PubMed ID: 6297214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical androgen receptor in the human melanoma cell line IIB-MEL-J.
    Morvillo V; Luthy IA; Bravo AI; Capurro MI; Donaldson M; Quintans C; Calandra RS; Mordoh J
    Pigment Cell Res; 1995 Jun; 8(3):135-41. PubMed ID: 7567789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoconazole binds to the human androgen receptor.
    Eil C
    Horm Metab Res; 1992 Aug; 24(8):367-70. PubMed ID: 1526623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin.
    Saartok T; Dahlberg E; Gustafsson JA
    Endocrinology; 1984 Jun; 114(6):2100-6. PubMed ID: 6539197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a [3H]methyltrienolone (R1881) binding protein in rat liver cytosol.
    Levinson DJ; Decker DE
    J Steroid Biochem; 1985 Feb; 22(2):211-9. PubMed ID: 3872380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer.
    Moguilewsky M; Fiet J; Tournemine C; Raynaud JP
    J Steroid Biochem; 1986 Jan; 24(1):139-46. PubMed ID: 3009970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.